Current Clinical Trials
SickKids is the only Canadian member of the National Cancer Institute Children’s Oncology Group (COG) Phase I consortium. In addition, clinicians and scientists in the Garron Family Cancer Centre at SickKids collaborate to translate scientific discoveries at SickKids into innovative early-phase paediatric cancer clinical trials. SickKids also collaborates with other cancer centres in Canada and worldwide, as well as with industry partners.
New Agents and Innovative Therapies Program
The New Agents and Innovative Therapies program (NAIT) provides access to promising new therapies for children with recurrent or refractory cancer. The NAIT program staff works closely with members of the leukemia/lymphoma, solid tumour and neuro-oncology sections of the Division of Hematology/Oncology to conduct Phase I/II clinical trials, and works with referring physicians at other Canadian centres to facilitate access to early phase trials for children from across Canada with recurrent or refractory cancers.